36 related articles for article (PubMed ID: 25193040)
21. Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan.
Matsumura Y; Yamamoto M; Nagao M; Hotta G; Matsushima A; Ito Y; Takakura S; Ichiyama S;
J Antimicrob Chemother; 2012 Nov; 67(11):2612-20. PubMed ID: 22843833
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of ST131 Clone Producing Both ESBL CTX-M-15 and AAC(6')Ib-cr Among Ciprofloxacin-Resistant
Alsharapy SA; Yanat B; Lopez-Cerero L; Nasher SS; Díaz-De-Alba P; Pascual Á; Rodríguez-Martínez JM; Touati A
Microb Drug Resist; 2018 Dec; 24(10):1537-1542. PubMed ID: 29883247
[No Abstract] [Full Text] [Related]
23. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain.
Blanco J; Mora A; Mamani R; López C; Blanco M; Dahbi G; Herrera A; Blanco JE; Alonso MP; García-Garrote F; Chaves F; Orellana MÁ; Martínez-Martínez L; Calvo J; Prats G; Larrosa MN; González-López JJ; López-Cerero L; Rodríguez-Baño J; Pascual A
J Antimicrob Chemother; 2011 Sep; 66(9):2011-21. PubMed ID: 21669946
[TBL] [Abstract][Full Text] [Related]
24. Molecular epidemiology and virulence of Escherichia coli O16:H5-ST131: comparison with H30 and H30-Rx subclones of O25b:H4-ST131.
Dahbi G; Mora A; Mamani R; López C; Alonso MP; Marzoa J; Blanco M; Herrera A; Viso S; García-Garrote F; Tchesnokova V; Billig M; de la Cruz F; de Toro M; González-López JJ; Prats G; Chaves F; Martínez-Martínez L; López-Cerezo L; Denamur E; Blanco J
Int J Med Microbiol; 2014 Nov; 304(8):1247-57. PubMed ID: 25455219
[TBL] [Abstract][Full Text] [Related]
25. Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea.
Lee MY; Choi HJ; Choi JY; Song M; Song Y; Kim SW; Chang HH; Jung SI; Kim YS; Ki HK; Son JS; Kwon KT; Heo ST; Yeom JS; Shin SY; Chung DR; Peck KR; Song JH; Ko KS
J Infect; 2010 Feb; 60(2):146-53. PubMed ID: 19932131
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and characteristics of lactose non-fermenting Escherichia coli in urinary isolates.
Chang J; Yu J; Lee H; Ryu H; Park K; Park YJ
J Infect Chemother; 2014 Nov; 20(11):738-40. PubMed ID: 25193040
[TBL] [Abstract][Full Text] [Related]
27. Escherichia coli ST1193: Following in the Footsteps of E. coli ST131.
Pitout JDD; Peirano G; Chen L; DeVinney R; Matsumura Y
Antimicrob Agents Chemother; 2022 Jul; 66(7):e0051122. PubMed ID: 35658504
[TBL] [Abstract][Full Text] [Related]
28. Population-based epidemiology of Escherichia coli ST1193 causing blood stream infections in a centralized Canadian region.
Peirano G; Matsumara Y; Nobrega D; DeVinney R; Pitout J
Eur J Clin Microbiol Infect Dis; 2021 Nov; ():. PubMed ID: 34750697
[TBL] [Abstract][Full Text] [Related]
29.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
